Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality

American Journal of Public Health

Volumn 89, Issue 8, 1999, Pages 1240-1244

  Weinstock, Martin A ^a,b   Gardstein, Betsey ^c  

^a BROWN UNIVERSITY   (United States)

^b PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS FUNGOIDES; RACE; SEX; UNITED STATES;

EID: 0032785255     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.89.8.1240     Document Type: Article

References (17)

1. Weinstock MA, Horm JW. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA. 1988;260: 42-46.
2. Iscovich J, Paltiel O, Azizi E, et al. Cutaneous lymphoma in Israel, 1985-1993: a population-based incidence study. Br J Cancer. 1998;77:170-173.
3. Chuang T-Y, Su WPD, Muller SA. Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol. 1990;23:254-256.
4. Bernstein L, Deapen D, Ross RK. Mycosis fungoides [letter]. JAMA. 1989;261:1882.
5. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications; 1982.
6. Mehta C, Patel N. StatXact 3 for Windows User Manual. Cambridge, Mass: Cytel Software Corp; 1997.
7. Greene MH, Dalager NA, Lamberg SI, Argyropoulos CE, Fraumeni JF. Mycosis fungoides: epidemiologic observations. Cancer Treat Rep. 1979;63:597-606.
8. Swanbeck G, Roupe G, Sandström MH. Indications of a considerable decrease in the death rate in mycosis fungoides by PUVA treatment. Acta Derm Venereol. 1994;74:465-466.
9. Merlino LA, Sullivan KJ, Whitaker DC, Lynch CF. The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. J Am Acad Dermatol. 1997;37:578-585.
10. Bolognia JL, Headley A, Fine J, Berwick M. Histologic evaluation of pigmented lesions in Connecticut and its influence on the reporting of melanoma. J Am Acad Dermatol. 1992;26: 198-202.
11. Karagas MR, Thomas DB, Roth GJ, Johnson LK, Weiss NS. The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State. Am J Epidemiol. 1991;133:58-62.
12. Seiffert J. Underreporting of melanoma. J Natl Cancer Inst. 1992;84:289.
13. Weinstock MA, Reynes J. Changing survival in mycosis fungoides: a population-based assessment of trends in the United States. Cancer. 1999;85:208-212.
14. Weinstock MA, Reynes JF. Validation of cause of death certification for outpatient cancers: the contrasting cases of melanoma and mycosis fungoides. Am J Epidemiol. 1998;148:1184-1186.
15. Wood GS, Salvekar A, Schaffer J, et al. Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. J Invest Dermatol. 1996;107:301-307.
16. Li G, Vowels BR, Benoit BM, Rook AH, Lessin SR. Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J Invest Dermatol. 1996;107:308-313.
17. Weinstock MA. Epidemiology of mycosis fungoides. Semin Dermatol 1994;13:154-159.